+ Follow CHEMOTHERAPY Tag
CHEMOTHERAPY
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1381908
[Title] => ‘Chemobrain’ may start before chemotherapy
[Summary] => The muddled thinking that sometimes affects breast cancer patients is manifested by decreased activity in a brain region that plays a key role in working memory, according to results of a functional imaging study.
[DatePublished] => 2014-10-19 00:00:00
[ColumnID] => 136231
[Focus] => 0
[AuthorID] => 1805110
[AuthorName] => Charles C. Chante MD
[SectionName] => Opinion
[SectionUrl] => opinion
[URL] =>
)
[1] => Array
(
[ArticleID] => 1252258
[Title] => FDA approves Roche drug for chronic leukemia based on research that it slows disease
[Summary] => The Food and Drug Administration on Friday approved a new drug from Roche to help treat patients with a type of cancer of the blood and bone marrow.
[DatePublished] => 2013-11-02 05:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => http://img534.imageshack.us/img534/3584/4nve.jpg
)
[2] => Array
(
[ArticleID] => 911748
[Title] => Hair, care, share: Hair loss adds to cancer trauma
[Summary] => The gravity of her son’s illness struck Maria Roleta Miranda hard when she saw strands of hair on the boy’s pillow one morning last week.
[DatePublished] => 2013-02-22 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => News Commentary
[SectionUrl] => news-commentary
[URL] =>
)
[3] => Array
(
[ArticleID] => 768485
[Title] => My head is now covered with hair
[Summary] => After months of chemotherapy and weeks of radiation, I am happy to share that the most critical and challenging part of my treatment is over.
[DatePublished] => 2012-01-18 00:00:00
[ColumnID] => 134670
[Focus] => 0
[AuthorID] => 1767481
[AuthorName] => Tetta Matera
[SectionName] => Fashion and Beauty
[SectionUrl] => fashion-and-beauty
[URL] =>
)
[4] => Array
(
[ArticleID] => 743585
[Title] => Roche launches drug for advanced ovarian cancer
[Summary] => Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
[DatePublished] => 2011-11-03 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[5] => Array
(
[ArticleID] => 742896
[Title] => First-line treatment for advanced ovarian cancer
[Summary] => Pharmaceutical company Roche recently launched an important milestone making its targeted therapy bevacizumab available for a disease where few treatment advances have been seen in over two decades.
[DatePublished] => 2011-11-01 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[6] => Array
(
[ArticleID] => 740509
[Title] => Breast cancer: Progress & promise in 2011
[Summary] => The field of breast cancer has been a model for innovation and discovery.
[DatePublished] => 2011-10-25 00:00:00
[ColumnID] => 133436
[Focus] => 0
[AuthorID] => 1778504
[AuthorName] => Tyrone M. Reyes M.D.
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => http://img714.imageshack.us/img714/6105/lif1thumba.jpg
)
[7] => Array
(
[ArticleID] => 712918
[Title] => Chavez prepares for second round of chemotherapy
[Summary] => Venezuelan President Hugo Chavez said Wednesday that he had well prepared himself both physically and spiritually for a second phase of chemotherapy to treat his cancer that would begin in the upcoming hours.
[DatePublished] => 2011-08-04 11:05:56
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[8] => Array
(
[ArticleID] => 696213
[Title] => Roche drug halves risk of disease worsening in women with recurrent ovarian cancer
[Summary] => Roche recently announced the results from OCEANS, a phase III study evaluating bevacizumab in combination with chemotherapy (gemcitabine and carboplatin) followed by the continued use of bevacizumab alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
[DatePublished] => 2011-06-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[9] => Array
(
[ArticleID] => 678152
[Title] => Roche bares positive results of breast cancer drug
[Summary] => BASEL, Switzerland — Roche has announced the topline results of its first randomized trial of trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer.
[DatePublished] => 2011-04-21 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
November 2, 2013 - 5:00am
November 3, 2011 - 12:00am
November 1, 2011 - 12:00am
